Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care ...
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care ...
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)
![PDF] GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a0653b7b38e796366a33a888639ab58e6f15b68e/4-Figure1-1.png "PDF] GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | Semantic Scholar")
PDF] GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | Semantic Scholar
ABILITY Diabetes Global: a major cooperation with our US partners | CERC Europe
Clinical Studies
PLOS Medicine: Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized ...
Explaining the jargon - Clinical Trials Explained
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study | Scientific Reports
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial - The Lancet
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial - The Lancet Neurology
Summary Of Active Clinical Trials For Prader-Willi Syndrome Hyperphagia - Prader-Willi Syndrome Association | USA
Parkinsonism & Related Disorders
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care ...
PPT - Blinding or Masking of Treatments and Other Aspects of the Trial PowerPoint Presentation - ID:2947805
Design of the trial. In this prospective, randomized, open-label,... | Download Scientific Diagram
Design of the trial. In this prospective, randomized, open-label,... | Download Scientific Diagram
STELARA® (ustekinumab) HCP Efficacy: Crohn's Disease (CD)
35 Open Label Study Advantages And Disadvantages - Labels For Your Ideas
Controlled studies and registries Christian TorpPedersen Aalborg University
